Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Millennium delivers ninth target to Wyeth-Ayerst for screening

Dec. 15, 1999

Bayer's Avelox approved in U.S. for treatment of respiratory illnesses

Dec. 14, 1999

Agouron's AG-7088 successfully completes phase II rhinovirus trial

Dec. 14, 1999

Novel truncated indolicidin analogues display broad-spectrum antimicrobial activity

Dec. 14, 1999

Janssen patents broad-spectrum azole antifungals with improved characteristics

Dec. 14, 1999

Versicor achieves milestone in antibacterial collaboration with Novartis

Dec. 13, 1999

"Inactive" pharmaceutical excipient demonstrates potent anti-HSV activity in vitro and in vivo

Dec. 13, 1999

P&U initiates European registration process for oxazolidinone

Dec. 10, 1999

Abbott signs licensing agreement with Wakunaga for two quinolone antibiotics

Dec. 10, 1999

PS-15 as monotherapy comparable to trimethoprim/sulfamethoxazole in mice with PCP

Dec. 9, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...